ArticleOncogene2024

Androgen-ablative therapies inducing CXCL8 regulates mTORC1/SREBP2-dependent cholesterol biosynthesis to support progression of androgen receptor negative prostate cancer cells.

Xingyu Xiong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.